Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells

Eitemau Tebyg

• Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells
  gan: Badur, Mehmet G., et al.
  Cyhoeddwyd: (2018)
• Metabolic consequences of oncogenic IDH mutations
  gan: Parker, Seth J., et al.
  Cyhoeddwyd: (2015)
• TMOD-14. CREATION OF A GENETICALLY ENGINEERED MOUSE MODEL OF ANAPLASTIC ASTROCYTOMA DRIVEN BY THE IDH1-R132H ONCOGENE
  gan: Shi, Diana, et al.
  Cyhoeddwyd: (2020)
• R-2-hydroxyglutarate as the key effector of IDH mutations promoting oncogenesis
  gan: Ye, Dan, et al.
  Cyhoeddwyd: (2013)
• D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth
  gan: Ma, Shenghong, et al.
  Cyhoeddwyd: (2015)